Related Experiment Videos
[Gene p53 mutation and prognosis in bladder tumors]
M Polito1, D Minardi, I Giannulis
1Clinica Urologica, Università degli Studi, Ancona.
Summary
The presence of p53 protein in bladder tumors correlates with disease stage and grade. Nuclear p53 reactivity indicates an increased risk of cancer relapse and progression, suggesting adjuvant treatment for early-stage transitional cell carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Bladder cancer treatment relies on pathological staging and grading.
- Tumorigenesis involves genetic alterations like oncogene activation and tumor suppressor gene inactivation.
- The p53 gene on chromosome 17 plays a crucial role in suppressing malignant transformation and maintaining DNA integrity.
Purpose:
- To investigate the correlation between p53 protein expression and clinicopathological features in transitional cell carcinoma of the bladder.
- To determine if p53 protein presence predicts tumor relapse and progression in patients undergoing conservative treatment.
Summary:
- Analyzed 60 transitional cell carcinoma bladder tumor samples stained for p53 protein.
- Observed a correlation between p53 protein presence, tumor staging, and grading.
- p53 protein expression was associated with an increased risk of cancer relapse and progression.
Impact:
- Nuclear p53 reactivity in localized transitional cell carcinoma suggests a higher risk of recurrence.
- Patients with p53-positive localized bladder cancer may benefit from adjuvant treatment protocols.
- This finding can refine risk stratification and treatment decisions for bladder cancer patients.